Mode
Text Size
Log in / Sign up
N/A Completed N=102 Randomized Single-blind Treatment

Retardation of Myopia in Orthokeratology

Source: ClinicalTrials.gov NCT00962208 ↗
Enrolled (actual)
102
Serious AEs
0.0%
Results posted
Sep 2013
Primary outcomePrimary: Axial Elongation in the Study and Control Subjects Who Completed the Two Years Study — 0.36; 0.63 mm

Summary

The primary aim of this study is to evaluate and compare the eyeball elongation in children wearing orthokeratology lenses and single-vision spectacles.

Outcome Measures

OutcomeResultp-value
PRIMARY
Axial Elongation in the Study and Control Subjects Who Completed the Two Years Study
0.36; 0.63
SECONDARY
Determine the Incidence of Adverse Effects in Cornea, the Palpebral, Bulbar and Tarsal Conjunctiva in the Study and the Control Groups
SECONDARY
Determine Changes in Other Ocular Parameters (e.g. Corneal Biomechanics and Aberration) Associated With Orthokeratology Lens Wear

Eligibility Criteria

Inclusion Criteria

  • Myopia (refractive sphere): > 0.50D and ≤ 4.00D
  • Astigmatism: 0.75D and ≤ 4.50D
  • Anisometropia: ≤ 1.50D in both refractive sphere, refractive cylinder and SE
  • Best corrected monocular visual acuity: equal to or better than 0.10 in logMAR scale in both eyes
  • Willingness for randomization
  • Willingness to wear contact lenses or spectacles on a daily basis
  • Availability for follow-up for at least 2 years

Exclusion Criteria

  • Strabismus at distance or near
  • Contraindication for contact lens wear and orthokeratology (e.g. limbus to limbus corneal cylinder and dislocated corneal apex
  • Prior experience with the use of rigid lenses (including orthokeratology)
  • Prior experience with myopia control treatment (e.g. refractive therapy or progressive add spectacles)
  • Systemic or ocular conditions which may affect contact lens wear (e.g. allergy and medication)
  • Systemic or ocular conditions which may affect refractive development (e.g. Down syndrome, ptosis)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00962208). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search